We compared the ER-MGINs of breast cancer and ovarian cancer, and found that, interestingly, the two networks shared no common in hub ER-MGs (defined as nodes with connectivity in the top 5%34), indicating the cancer-type specific feature of ER modulation. Here, ESR1 is linked to breast cancer.